Journal of Applied Biological Chemistry

The Korean Society for Applied Biological Chemistry (한국응용생명화학회)
권호 표지
DOI QR코드

DOI QR Code

Quercetin suppress CCL20 by reducing IκBα/STAT3 phosphorylation in TNF-α/IL-17A induced HaCaT cells

TNF-α/IL-17A 유도된 HaCaT 세포주에서 Quercetin의 IκBα/STAT3 인산화 조절에 의한 CCL20 발현 억제

  • Kim, Mi Ran (School of Cosmetic Science and Beauty Biotechnology, Semyung University) ;
  • Kim, Min Young (School of Cosmetic Science and Beauty Biotechnology, Semyung University) ;
  • Hwang, Hyung Seo (School of Cosmetic Science and Beauty Biotechnology, Semyung University)
  • Received : 2020.07.02
  • Accepted : 2020.08.19
  • Published : 2020.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Quercetin is a polyphenol compound with excellent antioxidant and anti-inflammatory activity. However, little has been reported about the efficacy of quercetin to control psoriasis. Thus, we aimed to investigate the effect of quercetin to regulate psoriatic dermatitis with HaCaT cell lines activated by TNF-α and IL-17A, which are in vitro psoriasis skin models. When quercetin was treated with TNF-α-activated HaCaT cell line, inflammatory cytokine expressions such as IL-1α, IL-1β and IL-6 were reduced by 49.1±7.14, 42.8±8.16, and 34.5±2.52%, respectively. In addition, mRNA expression levels of IL-8 and CCL20 the chemokines that attract immune cells such as Th17 cells and dendritic cells to the inflammatory reaction site, were also reduced by 38.4±5.83 and 52.9±4.59% compared to the TNF-α treatment group. The expression of proteins KRT6A and KRT16, which was nonspecifically increased in psoriatic skin was also significantly suppressed. Moreover, phosphorylation of IκBα and STAT3 proteins activated by TNF-α was also significantly inhibited. After stimulating the HaCaT with IL-17A, known as another psoriasis-inducing cytokine, it was observed that IκBα mRNA expression decreased by 55.8±5.28%, and STAT3 phosphorylation was downregulated by 36.3±6.81%. Finally, after co-activation by TNF-α/IL-17A, quercetin inhibited all of IL-1α, IL-1β, IL-6, TNF-α and CCL20 gene expression. The above results strongly suggest that quercetin is a material that has not only anti-oxidant and anti-inflammatory activities, but also has an activity in improving psoriasis.

Quercetin은 항산화 및 항염증 활성이 잘 알려져 있으나, 건선 피부염 조절에 대한 효능 연구는 거의 보고된 것이 없어, in vitro 건선 피부염 시험 모델인 TNF-α/IL-17A 유도 HaCaT 세포주를 이용해 quercetin에 의한 건선 피부염 개선 효과를 규명하였다. 먼저, TNF-α에 의해 활성화된 HaCaT 세포주에 quercetin을 처리한 결과, IL-1α, IL-1β, IL-6 등 염증성 사이토카인 발현이 TNF-α 처리군 대비 각각 49.1±7.14, 42.8±8.16, 34.5±2.52% 억제되었다. Th17세포 및 수지상세포 등 면역세포를 염증 반응 부위로 유인하는 케모카인 IL-8 및 CCL20의 mRNA 발현량 또한 TNF-α 처리군 대비 38.4±5.83, 52.9±4.59% 감소하였다. TNF-α 자극에 의해 건선피부에서 비특이적으로 증가되는 케라틴 단백질 KRT6A 및 KRT16 발현뿐만 아니라, IκBα 및 STAT3 단백질의 인산화 또한 quercetin에 의해 유의적으로 억제되었다. 또 다른 건선 유발 사이토카인으로 알려진 IL-17A로 HaCaT 세포주를 자극한 후 quercetin에 의한 영향을 관찰한 결과, IκBα mRNA 발현은 55.8±5.28% 감소하였고, STAT3 인산화는 36.3±6.81% 하향 조절되었다. 마지막으로 TNF-α/IL-17A를 동시 자극한 HaCaT 세포주에 quercetin을 처리한 결과, IL-1α, IL-1β, IL-6, TNF-α, CCL20 유전자 발현이 모두 억제되는 것을 확인하였다. 이를 통해 quercetin은 기존 항산화, 항염증 활성뿐만 아니라 건선 피부염 개선에 활성을 갖는 소재임을 확인할 수 있었다.

Keywords

References

  1. Lin TK, Zhong L, Santiago JL (2018) Anti-inflammatory and skin barrier repair effects of topical application of some plant oils. Int J Mol Sci 19: 70 https://doi.org/10.3390/ijms19010070
  2. Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454: 428-435 https://doi.org/10.1038/nature07201
  3. Chiricozzi A, Guttman-Yassky E, Suarez-Farinas M, Nograles KE, Tian S, Cardinale I, Chimentii S, Krueger JG (2011) Integrative responses to IL-17 and TNF-$\alpha$ in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 131: 677-687 https://doi.org/10.1038/jid.2010.340
  4. Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M (2018) Scanning the immunopathogenesis of psoriasis. Int J Mol Sci 19: 179 https://doi.org/10.3390/ijms19010179
  5. Ippagunta SK, Gangwar R, Finkelstein D, Vogel P, Pelletier S, Gingras S, Redecke V, Hacker H (2016) Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function. P Natl Acad Sci USA 113: E6162-E6171 https://doi.org/10.1073/pnas.1606996113
  6. Kennedy-Crispin M, Billick E, Mitsui H, Gulati N, Fujita H, Gilleaudeau P, Sullivan-Whalen M, Johnson-Huang LM, Suarez-Farinas M, Krueger JG (2012) Human keratinocytes' response to injury upregulates CCL20 and other genes linking innate and adaptive immunity. J Invest Dermatol 132: 105-113 https://doi.org/10.1038/jid.2011.262
  7. Schmuth M, Neyer S, Rainer C, Grassegger A, Fritsch P, Romani N, Heufler C (2002) Expression of the CC chemokine MIP3-$\alpha$/CCL20 in human epidermis with impaired permeability barrier function. Exp Dermatol 11: 135-142 https://doi.org/10.1034/j.1600-0625.2002.110205.x
  8. Izadpanah A, Dwinell MB, Eckmann L, Varki NM, Kagnoff MF (2001) Regulated MIP-3a/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol 280: G710-G719 https://doi.org/10.1152/ajpgi.2001.280.4.G710
  9. Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, Skorcheva I, Purdy D, Fitch E, Iordanov M, Blauvelt A (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129: 2175-2183 https://doi.org/10.1038/jid.2009.65
  10. Mabuchi T, Chang TW, Quinter S, Hwang ST (2012) Chemokine receptors in the pathogenesis and therapy of psoriasis. Eur J Pharmacol 65: 4-11
  11. Kuang YH, Lu Y, Liu YK, Liao LQ, Zhou XC, Qin Q S, Jia XK, Wu LS, Zhu W, Chen X (2018) Topical sunitinib ointment alleviates psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes. Eur J Pharmacol 824: 57-63 https://doi.org/10.1016/j.ejphar.2018.01.048
  12. Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, Catron D, Buchanan ME, Muller A, de Waal Malefyt R, Deng G, Orozco R, Ruzicka T, Lehmann P, Lebecque S, Caux C, Zlotnik A (2000) Up-regulation of macrophage inflammatory protein-$3{\alpha}$/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164: 6621-6632 https://doi.org/10.4049/jimmunol.164.12.6621
  13. Wang A, Wei J, Lu C, Chen H, Zhong X, Lu Y, Li L, Huang H, Dai Z, Han L (2019) Genistein suppresses psoriasis-related inflammation through a STAT3-NF-${\kappa}B$-dependent mechanism in keratinocytes. Int immunopharmacol 69: 270-278 https://doi.org/10.1016/j.intimp.2019.01.054
  14. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, Itami Satoshi, Nickoloff BJ, DiGiovanni J (2005) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11: 43-49 https://doi.org/10.1038/nm1162
  15. Andres RM, Montesinos MC, Navalon P, Paya M, Terencio MC (2013) NF-${\kappa}B$ and STAT3 inhibition as a therapeutic strategy in psoriasis: In vitro and in vivo effects of BTH. J Invest Dermatol 133: 2362-2371 https://doi.org/10.1038/jid.2013.182
  16. Wang YN, Chang WC (2003) Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun. J Biol Chem 278: 45848-45857 https://doi.org/10.1074/jbc.M302630200
  17. Paramio JM, Casanova ML, Segrelles C, Mittnacht S, Lane EB, Jorcano JL (1999) Modulation of cell proliferation by cytokeratins K10 and K16. Mol Cell Biol 19: 3086-3094 https://doi.org/10.1128/MCB.19.4.3086
  18. Zhang X, Yin M, Zhang LJ (2019) Keratin 6, 16 and 17-Critical Barrier Alarmin Molecules in Skin Wounds and Psoriasis. Cells 8: 807 https://doi.org/10.3390/cells8080807
  19. Zhang LJ (2018) Keratins in Skin Epidermal Development and Diseases. IntechOpen, London
  20. Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M (2001) Keratins and the keratinocyte activation cycle. J Invest Dermatol 116: 633-640 https://doi.org/10.1046/j.1523-1747.2001.01327.x
  21. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, Liu H, Yin Y (2016) Quercetin, inflammation and immunity. Nutrients 8: 167 https://doi.org/10.3390/nu8030167
  22. Dabeek WM, Marra MV (2019) Dietary Quercetin and Kaempferol: bioavailability and potential cardiovascular-related bioactivity in humans. Nutrients 11: 2288 https://doi.org/10.3390/nu11102288
  23. Wang R, Zhang H, Wang Y, Song F, Yuan Y (2017) Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-${\kappa}B/I{\kappa}B{\alpha}$, p38 MAPK, and Bcl-2/Bax signaling. Int Immunopharmacol 47: 126-133 https://doi.org/10.1016/j.intimp.2017.03.029
  24. Yahfoufi N, Alsadi N, Jambi M, Matar C (2018) The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients 10: 1618 https://doi.org/10.3390/nu10111618
  25. Carrasco-Pozo C, Tan KN, Reyes-Farias M, De La Jara N, Ngo ST, Garcia-Diaz DF, Llanos P, Cires MJ, Borges K (2016) The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic $\beta$-cells, glycemic control and inflammation: In vitro and in vivo studies. Redox Biol 9: 229-243 https://doi.org/10.1016/j.redox.2016.08.007
  26. Endale M, Park SC, Kim S, Kim SH, Yang Y, Cho JY, Rhee MH (2013) Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-${\kappa}B$-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology 218: 1452-1467 https://doi.org/10.1016/j.imbio.2013.04.019
  27. Yang D, Liu X, Liu M, Chi H, Liu J, Han H (2015) Protective effects of quercetin and taraxasterol against $H_2O_2$-induced human umbilical vein endothelial cell injury in vitro. Exp Ther Med 10: 1253-1260 https://doi.org/10.3892/etm.2015.2713
  28. Chen H, Lu C, Liu H, Wang M, Zhao H, Yan Y, Han L (2017) Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-${\kappa}B$ pathway. Int Immunophamacol 48: 110-117 https://doi.org/10.1016/j.intimp.2017.04.022
  29. Zhao L, Xia J, Wang X, Xu F (2014) Transcriptional regulation of CCL20 expression. Microbes Infect 16: 864-870 https://doi.org/10.1016/j.micinf.2014.08.005
  30. Jin W, Dong C (2013) IL-17 cytokines in immunity and inflammation. Emerg Microbes Infect 2: 1-5 https://doi.org/10.1038/emi.2013.58
  31. Yuan S, Zhang S, Zhuang Y, Zhang H, Bai J, Hou Q (2015) Interleukin-17 stimulates STAT3-mediated endothelial cell activation for neutrophil recruitment. Cell Physiol Biochem 36: 2340-2356 https://doi.org/10.1159/000430197
  32. Udommethaporn S, Tencomnao T, McGowan EM, Boonyaratanakornkit V (2016) Assessment of anti-TNF-$\alpha$ activities in keratinocytes expressing inducible TNF-$\alpha$: a novel tool for anti-TNF-$\alpha$ drug screening. PloS one 11: e0159151 https://doi.org/10.1371/journal.pone.0159151
  33. Anand David AV, Arulmoli R, Parasuraman S (2016) Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacogn Rev 10: 84 https://doi.org/10.4103/0973-7847.194044
  34. Xiong H, Xu Y, Tan G, Han Y, Tang Z, Xu W, Zeng F, Guo Q (2015) Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-$\alpha$-induced ICAM-1 expression via NF-${\kappa}B$/MAPK in HaCaT cells. Cell Physiol Biochem 35: 1335-1346 https://doi.org/10.1159/000373955
  35. Furue M, Furue K, Nakahara T (2020) Interleukin-17A and Keratinocytes in Psoriasis. Int J Mol Sci 21: 1275 https://doi.org/10.3390/ijms21041275
  36. Tak PP, Firestein GS (2001) NF-${\kappa}B$: a key role in inflammatory diseases. J Clin Invest 107: 7-11 https://doi.org/10.1172/JCI11830
  37. Hayden MS, Ghosh S (2014) Regulation of NF-${\kappa}B$ by TNF family cytokines. Semin Immunol (Vol. 26, No. 3, pp. 253-266). Academic Press
  38. Hatada EN, Krappmann D, Scheidereit C (2000) NF-${\kappa}B$ and the innate immune response. Curr Opin Immunol 12: 52-58 https://doi.org/10.1016/S0952-7915(99)00050-3
  39. Park K, Lee JH, Cho HC, Cho SY, Cho JW (2010) Down-regulation of IL-6, IL-8, TNF-$\alpha$ and IL-$1{\beta}$ by glucosamine in HaCaT cells, but not in the presence of TNF-$\alpha$. Oncol Lett 1: 289-292 https://doi.org/10.3892/ol_00000051
  40. McFarland BC, Hong SW, Rajbhandari R, Twitty GB Jr, Gray GK, Yu H, Benveniste EN, Nozell SE (2013) NF-${\kappa}B$-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma. PLoS One 8: e78728 https://doi.org/10.1371/journal.pone.0078728
  41. Meares GP, Ma X, Qin H, Benveniste EN (2012) Regulation of CCL20 expression in astrocytes by IL-6 and IL-17. Glia 60: 771-781 https://doi.org/10.1002/glia.22307
  42. Jiang M, Li B, Zhang J, Hu L, Dang E, Wang G (2017) Vascular endothelial growth factor driving aberrant keratin expression pattern contributes to the pathogenesis of psoriasis. Exp Cell Res 360: 310-319 https://doi.org/10.1016/j.yexcr.2017.09.021